UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
When To Choose A Benchmark Over A Strategic Index explains decision points for selecting benchmarks based on goals, cost, and risk tolerance.
25,499 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Oil prices cooled after news that wealthy nations may coordinate an emergency reserve release. Analysts warn that pri...
The Senate cleared a sweeping housing package in a rare bipartisan vote, setting up aHouse showdown and potential shi...
An 8% jump can feel exciting, but a smart investor asks: what’s next? This guide breaks down how to assess a sudden m...
A major filming pause on secret lives mormon wives reveals how volatile reality TV income can be. This guide breaks d...
A landmark joint interpretive guidance from the SEC and CFTC clarifies crypto regulation, focusing on security classi...
A coordinated strike on gas facilities has sparked a rapid escalation between Israel and Iran, sending energy prices ...
A large investment fund recently exited its stake in Asbury Automotive, triggering headlines about insider selling. T...
Indiana Regional MLS is rolling out Navigator by Lundy AI to unify compliance knowledge for its MLS and shareholder a...
A new class of job-search firms charges up front fees to run an entire hunt for candidates. The market that reverse r...
Exelon is tapping into accelerating AI data-center demand in Illinois, with Citi signaling upside and a $58 target by...
World Liberty Financial, linked to the Trump family, launches a defamation lawsuit against a billionaire after a prev...